International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8089102
Original Article
Prevalence of Ischemic Heart Disease in Patients Undergoing SICS, Intraoperative and Postoperative Complications in these Patients- An Observational Study
 ,
 ,
Published
June 28, 2023
Abstract

Background: To study the preoperative, intraoperative and postoperative complications and to study postoperative visual outcome in these patients.

Methods: This is a prospective observational study conducted on a study population of 43 patients who were diagnosed with IHD (ejection fraction >40%). Complete ophthalmic examination with slit lamp, fundus examination, intraocular pressure, biometry was performed. All patients underwent thorough cardiac evaluation and fitness for cataract surgery under local anaesthesia was obtained.Lignocaine2% without adrenaline was used for local anaesthesia. Systemic medications like aspirin and other blood thinners were stopped 5-7 days before surgery. These patients were subjected to the same protocol of Manual small incision cataract surgery like all other patients. Final visual acuity was accessed at the end of 6weeks.

Results: Of the 43 patients with IHD,15 patients (34.89%) were in age group of 45-60 yr,23 patients (53.48%) were in age group of 60-70yr,5 patients (11.62%) were above 70years. 8 patients (18.6%) had intraoperative bleeding from sclero corneal tunnel,4 patients (9.3%) had postoperative subconjunctival haemorrhage. All 43 patients (100%) achieved 6/9 to 6/6 postoperative vision at 6 week follow up. None of the patients had any systemic complications like decrease of saturation, variation in heart rate during surgery.

Conclusion: In patients with IHD who undergo cataract surgery, complications can be minimized by proper preoperative evaluation and intraoperative care. Surgery done with precaution will reduce intraoperative complications and gives good visual outcome

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2950 Views
228 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved